Xbrane Biopharma AB (publ) (STO:XBRANE)

Xbrane Biopharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	197	210	30,743	34	256	297
Market Cap Growth	-56.30%	-99.32%	90868.17%	-86.80%	-13.94%	58.03%
Enterprise Value	211.2	181.89	30,810	199.87	100.24	46.7
Last Close Price	9.56	10.20	20.10	141.71	1163.43	1485.10

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	-	127.50	-	-	-	-
Forward PE	-	2.45	18.40	27.74	13.18	20.01
PS Ratio	2.36	1.38	207.58	0.14	4.44	27.78
PB Ratio	0.37	0.37	147.42	0.20	0.60	0.69
P/TBV Ratio	32.90	0.64	8.09	9.37	0.74	0.73

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	2.54	1.19	208.04	0.84	1.74	4.36

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.01	0.10	0.46	0.91	0.07	0.08
Net Debt / Equity Ratio	0.03	-0.05	0.32	0.97	-0.37	-0.58
Net Debt / EBITDA Ratio	-0.21	3.98	-1.10	-0.56	1.02	1.42
Net Debt / FCF Ratio	-0.11	0.11	-0.50	-0.40	0.76	1.01
Asset Turnover	0.13	0.20	0.20	0.36	0.08	0.03
Inventory Turnover	0.42	0.28	0.10	2.59	0	-
Quick Ratio	0.71	1.88	0.29	0.31	1.02	1.57
Current Ratio	3.19	7.12	1.13	1.41	2.17	2.55
Return on Equity (ROE)	-13.46%	-12.00%	-74.40%	-108.02%	-39.34%	-53.15%
Return on Assets (ROA)	-10.32%	-3.92%	-14.16%	-44.15%	-22.14%	-45.38%
Return on Invested Capital (ROIC)	-12.49%	-7.34%	-34.53%	-97.84%	-67.84%	-174.91%
Return on Capital Employed (ROCE)	-11.66%	-6.12%	-30.79%	-75.99%	-33.09%	-95.63%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	-	0.78%	-	-	-	-
Buyback Yield / Dilution	97.34%	0.00%	-246.95%	-2215.66%	-8.38%	-30.25%
Total Shareholder Return	97.34%	0.00%	-246.95%	-2215.66%	-8.38%	-30.25%

Data Source: Fiscal.ai Last updated: May 5, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 13, 2026

Data Sources Report a data error